ArticleFrontiers in toxicology2022

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.

Liam Simms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.